NCT05632848 2025-07-21Chidamide Combined With Zimberelimab in the Treatment of Metastatic Triple-negative Breast Cancer PatientsSun Yat-sen UniversityPhase 2 Completed47 enrolled
NCT03629756 2024-05-24A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced MalignanciesArcus Biosciences, Inc.Phase 1 Completed48 enrolled